Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Wisny Docteur"'
Autor:
Helena Huerga, Elmira A. Berikova, M.R. Khan, Lawrence Oyewusi, Kerow Hussein, Andargachew Kumsa, Molly F. Franke, Carole D. Mitnick, Michael Rich, Leonid Lecca, Manzurul Alam, Parvati Nair, Nino Chumburidze, Mishaz Mudassar, Nazgul Samieva, Khin Zarli, Wisny Docteur, Palwasha Khan, Saman Ahmed, Hakob Atshemyan, Sidney Atwood, Mathieu Bastard, Putri Lenggogeni, Cathy Hewison, S.S. Islam, Kwonjune J. Seung, Uzma Khan, Nara Melikyan
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
We regret that this article is behind a paywall.
Background Bedaquiline and delamanid offer the possibility of more effective and less toxic multidrug-resistant tuberculosis (MDR-TB) treatment. With this treatment, however, some patients, remain
Background Bedaquiline and delamanid offer the possibility of more effective and less toxic multidrug-resistant tuberculosis (MDR-TB) treatment. With this treatment, however, some patients, remain
Autor:
Yoseph Melaku Tassew, S.S. Islam, Catherine Hewison, Kwonjune J. Seung, Manzur Alam, Fauziah Asnely Putri, Wisny Docteur, Andargachew Kumsa, Palwasha Khan, Carole D. Mitnick, Lawrence Oyewusi, Leonid Lecca, Saman Ahmed, Naira Khachatryan, Helena Huerga, Stephen Wanjala, Mathieu Bastard, Stalbek Aiylchiev, Tinatin Kotrikadze, Molly F. Franke, Michael Rich, Ye Yint Naing, Askar Yedilbayev, Nara Melikyan, Gary L. Gottlieb, Uzma Khan
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71(2)
Delamanid should be effective against highly resistant strains of Mycobacteriumtuberculosis, but uptake has been slow globally. In the endTB (expand new drug markets for TB) Observational Study, which enrolled a large, heterogeneous cohorts of patien